Cameron Rokhsar is a Dermatology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 20 publications with 769 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
328 E 75th St
Suite A
New York, NY 100213317
Telephone
212-285-1110Provider last certified this registry record 16 Sept 2020.
Clinical trials
- Feasibility Study: Lifting and Tightening of the Elbows
Sponsor: Ulthera, Inc
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20252 payments
- MERZ NORTH AMERICA, INC.Program year20251 payment
- Amgen Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
56.4%First-generation cephalosporins34.4%Cefadroxil100%Part D≥65 patientsLincosamide Antibacterial14.8%Clindamycin Phosphate51%Clindamycin Hcl49%Part D<11 patients+ 1 more class in this area
Sensory organs
31.6%Corticosteroid31.6%Clobetasol Propionate84%Hydrocortisone17%Part D≥36 patientsRespiratory
6.8%RNA Synthetase Inhibitor Antibacterial6.8%Mupirocin100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Allison McGeer
Mount Sinai Hospital
Scott Sicherer, MD
Mount Sinai Hospital
Ulrich Specks
Mount Sinai Hospital
Jorge Sánchez‐Guerrero
Mount Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”